Search filters

List of works by Nolan J Maloney

Alopecia areata as an immune-related adverse event of immune checkpoint inhibitors: a review

scientific article published on 16 August 2020

Cutaneous spindle cell sarcoma: a population-based study in the surveillance, epidemiology, and end results database from 1975 to 2016

scientific article published on 04 September 2019

Destabilization of MYC/MYCN by the mitochondrial inhibitors, metaiodobenzylguanidine, metformin and phenformin

scientific article published on November 2013

Development of alopecia in patients treated with dupilumab

scientific article published on 18 March 2019

Development of alopecia in patients treated with interleukin-17 inhibitors

scientific article published on 11 November 2020

Neutrophilic dermatoses as adverse effects of checkpoint inhibitors: A review

scientific article published on 04 September 2019

Off-Label studies on anakinra in dermatology: a review

scientific article published on 11 April 2020

Off-label studies on apremilast in dermatology: a review

scientific article published on 02 April 2019

Off-label studies on tofacitinib in dermatology: a review

scientific article published on 03 October 2019

Overlap between hemophagocytic lymphohistiocytosis and drug reaction and eosinophilia with systemic symptoms: a review

scientific article published on 21 September 2020

Patient experiences with biologics and apremilast in pityriasis rubra pilaris: A patient survey

scientific article published on 18 August 2019

Primary mucoepidermoid carcinoma of the skin: a retrospective investigation in the Surveillance, Epidemiology, and End Results Database from 1975 to 2016

scientific article published on 12 December 2019

Refractory pityriasis rubra pilaris treated with etanercept, adalimumab, or ustekinumab: A retrospective investigation.

scientific article published on 15 October 2017

Stevens-Johnson syndrome and toxic epidermal necrolysis-like reactions to checkpoint inhibitors: a systematic review

scientific article published on 13 February 2020

Sweet Syndrome as an Adverse Reaction to Tyrosine Kinase Inhibitors: a review

scientific article published on 28 October 2020

Type I pityriasis rubra pilaris treated with tumor necrosis factor inhibitors, ustekinumab, or secukinumab: A review

scientific article published on 05 March 2018